Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as IKK inhibitors

Details for Australian Patent Application No. 2006268531 (hide)

Owner Sanofi-Aventis

Inventors Olsen, Jacob-Alsboek; Bosch, Michael; Jegham, Samir; Mignani, Serge; Casellas, Pierre; Bouaboula, Monsif; Tonnerre, Bernard; Wagnon, Jean; Nguefack, Jean-Flaubert

Agent A J Park

Pub. Number AU-A-2006268531

PCT Pub. Number WO2007/006926

Priority 0511950 25.11.05 FR; 0507370 11.07.05 FR

Filing date 6 July 2006

Wipo publication date 18 January 2007

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/351 (2006.01) - not condensed with another ring

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/006926 Priority application(s): WO2007/006926

22 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006268553-Method for evaluating cell populations

2006268527-Novel 1H-indole-pyridinecarboxamide and 1H-indole-piperidinecarboxamide derivatives and their use as hydroxylase tyrosine inducers